Pacifica Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Pacifica Partners's GILD Position: Q2 2026 in Review
Pacifica Partners reduced its Gilead Sciences (GILD) stake by 5.5% in Q2 2026, selling an estimated $2.37K and leaving 310 shares worth $40.7K. The position accounts for 0.01% of the portfolio, ranked #201.
Pacifica Partners first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $45.7K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Pacifica Partners held 310 shares of Gilead Sciences worth $40.7K as of Q2 2026.
- Pacifica Partners sold 18 Gilead Sciences shares in Q2 2026, an estimated $2.37K.
- Gilead Sciences made up 0.01% of Pacifica Partners's portfolio in Q2 2026, its #201 holding.
- Pacifica Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
- Pacifica Partners's Gilead Sciences position peaked at $45.7K in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.